Diabetes, Vol 43, Issue 1 80-86, Copyright © 1994 by American Diabetes Association

ARTICLES

Autoantibodies to glutamic acid decarboxylase in patients with IDDM and autoimmune thyroid disease

E Kawasaki, H Takino, M Yano, S Uotani, K Matsumoto, Y Takao, Y Yamaguchi, S Akazawa and S Nagataki
First Department of Internal Medicine, Nagasaki University School of Medicine, Japan.

Autoantibodies to glutamic acid decarboxylase (GAD), previously reported to be the 64,000-M(r) (64K) islet cell protein, were measured by a radioimmunoassay using purified pig brain GAD in 29 insulin-dependent diabetes mellitus (IDDM) patients with autoimmune thyroid disease (AITD) and in 29 sex- and disease duration-matched IDDM patients without AITD. Islet cell antibodies (ICAs) and 64K antibodies were also determined. In IDDM patients with short-duration diabetes (< 1 year), the prevalence and levels of GAD antibodies were 100% (8 of 8) and 609 +/- 166 U (means +/- SE), respectively, in IDDM patients with AITD and 81.8% (9 of 11) and 90 +/- 51 U, respectively, in patients without AITD. In patients with long-standing IDDM (3-22 years), the prevalence and levels of GAD antibodies were 76.2% (16 of 21) and 193 +/- 66 U, respectively, in patients with AITD and 50.0% (9 of 18) and 36 +/- 14 U, respectively, in patients without AITD. For up to 6 years after the onset of IDDM, the levels of GAD antibodies in IDDM patients with AITD were significantly higher than in IDDM patients without AITD. A close and significant correlation was found between GAD antibodies and ICA or 64K antibodies in IDDM patients with AITD. Our results demonstrate that high levels of GAD antibodies were present in IDDM patients with AITD. The observed differences in GAD immunoreactivity between IDDM patients with and without AITD might help evaluate the role of GAD antibodies in IDDM.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				N. Ozaki, Y. Miura, and Y. Oiso A Case of Type 1 Diabetes Followed by Methimazole-Induced Hypersensitivity Syndrome Diabetes Care, May 1, 2006; 29(5): 1179 - 1180. [Full Text] [PDF]

				C. Pihoker, L. K. Gilliam, C. S. Hampe, and A. Lernmark Autoantibodies in Diabetes Diabetes, December 1, 2005; 54(suppl_2): S52 - S61. [Abstract] [Full Text] [PDF]

				M. Mochizuki, S. Amemiya, K. Kobayashi, K. Kobayashi, Y. Shimura, T. Ishihara, Y. Nakagomi, K. Onigata, S. Tamai, A. Kasuga, et al. Association of the CTLA-4 Gene 49 A/G Polymorphism With Type 1 Diabetes and Autoimmune Thyroid Disease in Japanese Children Diabetes Care, March 1, 2003; 26(3): 843 - 847. [Abstract] [Full Text] [PDF]

				H. Takeda, E. Kawasaki, I. Shimizu, E. Konoue, M. Fujiyama, S. Murao, K. Tanaka, K. Mori, Y. Tarumi, I. Seto, et al. Clinical, Autoimmune, and Genetic Characteristics of Adult-Onset Diabetic Patients With GAD Autoantibodies in Japan (Ehime Study) Diabetes Care, June 1, 2002; 25(6): 995 - 1001. [Abstract] [Full Text] [PDF]

				C. E. M. De Block, I. H. De Leeuw, K. Decochez, F. Winnock, J. Van Autreve, C. M. Van Campenhout, M. Martin, and F. K. Gorus The Presence of Thyrogastric Antibodies in First Degree Relatives of Type 1 Diabetic Patients Is Associated with Age and Proband Antibody Status J. Clin. Endocrinol. Metab., September 1, 2001; 86(9): 4358 - 4363. [Abstract] [Full Text] [PDF]

				K. Yoshioka, T. Ando, K.-i. Inoue, N. Hiraoka, Y. Kasamatsu, T. Yoshida, and M. Kondo Esophageal Stenosis and Graves Disease in Brittle Type 1 Diabetes Mellitus Arch Intern Med, June 22, 1998; 158(12): 1380 - 1381. [Full Text] [PDF]

				T. Kitagawa, M. Owada, T. Urakami, and K. Yamauchi Increased Incidence of Non-Insulin Dependent Diabetes Mellitus Among Japanese Schoolchildren Correlates with an Increased Intake of Animal Protein and Fat Clinical Pediatrics, February 1, 1998; 37(2): 111 - 115. [Abstract] [PDF]